Activist investor Starboard accuses Pfizer of strong-arming former execs into backing CEO Bourla ahead of strategy meeting
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting with activist investor Starboard Value, Pfizer's former CEO and CFO publicly changed their tune after being threatened with litigation by Pfizer,
Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...
In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...
Former Pfizer Inc. executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist ...
Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...
On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer (NYSE: PFE) ...
The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...
Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, ...
With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback